Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.

Annals of surgical oncology - 1 Jan 2024

Shelton Charles, Ruiz Antonio, Shelton Lauren, Montgomery Hannah, Freas Karen, Ellsworth Rachel E, Poll Sarah, Pineda-Alvarez Daniel, Heald Brandie, Esplin Edward D, Nielsen Sarah M

Abstract excerpt

BACKGROUND: Whereas the National Comprehensive Cancer Network (NCCN) criteria restrict germline-genetic testing (GGT) to a subset of breast cancer (BC) patients, the American Society of Breast Surgeons recommends universal GGT. Although the yield of pathogenic germline variants (PGV) in unselected BC patients has been studied, the practicality and utility of incorporating universal GGT into routine cancer care in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Germ Cells

Share to Germ-Line Mutation

Share to Rural Population

Source

Open in PubMed Open full text

Identifiers

PMID: 37814187
DOI: 10.1245/s10434-023-14394-3
PMCID: PMC10695880

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.PMID 37814187Read ↗

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.Semantic proximity Read ↗

Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.Semantic proximity Read ↗

Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care.Semantic proximity Read ↗

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathwaySemantic proximity Read ↗

Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.Semantic proximity Read ↗

Genetic testing and surgical treatment after breast cancer diagnosis: Results from a national online cohort.Semantic proximity Read ↗

Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to ActionSemantic proximity Read ↗

Pivotal Role of Genetic Counselors in the Uptake of Germline Genetic Testing in Non-Metastatic Breast Cancer and the Impact of Testing on Surgical Decision Making.Semantic proximity Read ↗

The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART studySemantic proximity Read ↗

Germline BRCA testing in routine clinical practice: a single-center experience.Semantic proximity Read ↗

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.Semantic proximity Read ↗

Germline Genetic Testing After Cancer DiagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.